Clinical Start-up PERT Estimate

Clinical study start-up three-point PERT

This three-point PERT chart estimates clinical study start-up while exposing uncertainty in regulatory review and site activation. A draft protocol begins ethics review and site selection. Selected sites are contracted, then training waits for both the ethics decision and signed site contracts. Enrollment opens only after training. Optimistic, likely and pessimistic durations give the team a way to plan around review timing and contract variability without treating them as fixed. Extend the network with budget approval, investigator meetings, data-system validation or drug supply release when those steps affect study activation.

種類 PERT / ガントチャート規格 PMI PMBOK 7 + Moder 1983 (AON/PDM)エンジン schematex-pert更新日 2026/9/24

依頼内容

“Create a three-point PERT estimate for clinical study start-up: draft protocol, complete ethics review, select sites, contract sites, train sites, then open enrollment.”

次はこちらAdd a data-system validation before enrollment.Change the likely ethics review duration to fourteen days.

この図に含まれるもの

図の背後にある意思決定を読み解く。

01Protocol gate

Ethics and site selection begin after the draft.

02Site gate

Contracting follows selection.

03Activation gate

Training needs ethics approval and contracts.

Use for an early clinical study plan.

PERT / ガントチャートのテンプレートをすべて見る →

よくある質問

Why use three-point estimates?

Review and contracting durations are uncertain.

What blocks training?

Ethics review and site contracts.

When does enrollment open?

After site training.